Introduction to Phase One Interceptive Orthodontic Treatment
Phase One treatment, occurring during the mixed dentition period (ages 6–10 years), represents a critical window for orthodontic intervention. This early treatment phase capitalizes on the patient's remaining skeletal growth and the natural shedding of primary dentition to address significant dental and skeletal discrepancies before they become compounded during permanent dentition eruption. The primary objectives of Phase One treatment include correcting transverse skeletal discrepancies (crossbites), managing space deficiencies, modifying growth patterns, and preventing the development of severe malocclusions that would necessitate comprehensive surgical-orthodontic correction in adulthood. Evidence-based research supports early intervention in selected cases where skeletal discrepancies are moderate to severe, as untreated conditions often worsen with growth and development.
Phase One interceptive treatment is distinctly different from simple preventive or maintenance care. Rather than simply monitoring eruption patterns, Phase One treatment actively applies corrective forces to guide skeletal development and manage dental crowding. Research by Tulloch and colleagues (1998) demonstrated that early treatment of Class II malocclusions reduced the complexity and duration of subsequent Phase Two comprehensive treatment. The decision to initiate Phase One treatment requires careful diagnostic evaluation, including clinical examination, radiographic assessment, and consideration of growth potential. Not all patients with early malocclusion require Phase One treatment; selective application to patients with significant transverse, vertical, or anterior-posterior discrepancies yields the greatest benefits.
Diagnosis and Treatment Planning for Early Intervention
Accurate diagnosis during the mixed dentition phase is essential for determining candidacy for Phase One treatment. Orthodontists assess patients using a comprehensive analysis that includes clinical examination, cephalometric radiographs, cone beam computed tomography (CBCT) when indicated, and functional assessment of the occlusion. Key diagnostic indicators for Phase One intervention include anterior or posterior crossbites (affecting 5–10% of the population), significant overjet or overbite, severe dental crowding, functional shifts of the mandible, or evidence of skeletal discrepancy on cephalometric analysis. Cephalometric landmarks such as the ANB angle (anteroposterior skeletal relationship), SN-GoGn (vertical dimension), and U1-NA/L1-NB angles (incisor inclination) guide the diagnosis of skeletal Class II, Class III, or vertical growth patterns.
The cervical vertebral maturation (CVM) method provides a non-invasive assessment of skeletal maturity using lateral cephalometric radiographs, enabling clinicians to predict the remaining growth potential and optimal timing for orthopedic intervention. Patients demonstrating skeletal Class II characteristics with favorable growth patterns—such as horizontal growth direction and anterior maxillary deficiency—are ideal candidates for Phase One treatment using functional appliances or expansion devices. Conversely, patients with severe anterior skeletal open bite, excessive vertical growth, or Class III patterns with mandibular prognathism may require modified Phase One approaches or delayed treatment until skeletal maturity allows comprehensive surgical correction.
Crossbite Correction and Transverse Plane Management
Posterior crossbites occur in approximately 8–13% of children during the mixed dentition and require early intervention because self-correction rarely occurs after permanent dentition eruption. Unilateral crossbites are often accompanied by a functional shift of the mandible toward the crossbite side, which creates an asymmetrical growth stimulus and perpetuates asymmetrical skeletal development. Early correction of crossbites using maxillary expansion appliances—such as rapid palatal expanders (RPE), slow maxillary expanders (SME), or removable expanders—can normalize the transverse dimension before the palatal sutures ossify completely, typically by age 14–16 years. The RPE applies a direct force to the maxillary first molars and first premolars, creating forces of 4–6 kg per quarter-turn, while SME applies lighter intermittent forces of 0.5–2 kg over weeks or months.
The biological response to maxillary expansion involves separation of the midpalatal suture with subsequent bone deposition and widening of the maxillary base. Radiographic evidence demonstrates that rapid palatal expansion widens the distance between maxillary molars, increases intermolar width by 4–8 mm, and can increase nasal width by 2–3 mm. Correction of posterior crossbites during mixed dentition reduces compensatory movements of permanent teeth, improves nasal airway dimensions (documented on CBCT), and enhances the potential for normal subsequent permanent dentition development. Anterior crossbites, less common but more concerning for growth modification, also benefit from early correction using maxillary protraction masks (face-mask appliances) or fixed appliance therapy to restore normal anterior-posterior relationships and prevent dentoalveolar compensation.
Space Management and Arch Development
Dental crowding during mixed dentition affects approximately 30–40% of the population and represents one of the most common reasons for Phase One intervention. Mixed dentition crowding typically results from a discrepancy between available arch space and tooth size; the "mixed dentition analysis" (such as the Tanaka-Johnston analysis or Moyers method) predicts the combined mesiodistal width of unerupted canines and premolars using radiographically measured first permanent molars and incisors. When space deficiency is predicted—commonly 4–8 mm in severely crowded patients—early space management through selective serial extraction, arch development, or other interceptive means can improve the probability of alignment during Phase Two treatment.
Serial extraction (or planned extraction) protocols involve timely removal of specific primary canines and first molars to create space for eruption of permanent canines and premolars, reducing subsequent crowding and the need for permanent tooth extraction. The timing of serial extraction is critical: primary canines are removed when their root resorption is 50%, typically around age 8–9 years, followed by extraction of primary first molars after permanent canines have erupted approximately halfway, around age 9–10 years. Clinical evidence suggests that strategic serial extraction reduces overall treatment time during Phase Two and improves final tooth alignment compared to unrestricted eruption followed by comprehensive extraction-based mechanics. However, serial extraction is contraindicated in cases with adequate space or where anterior-posterior discrepancies indicate the need for comprehensive treatment planning.
Growth Modification and Functional Appliance Therapy
Phase One treatment in Class II patients often incorporates functional appliances designed to capitalize on remaining skeletal growth and reposition the mandible forward. Functional appliances, including the Frankel regulator, Herbst appliance, Twin Block, and Activator, mechanically displace the mandible to a more anterior position, stimulating condylar cartilage growth and favorable skeletal changes. Research demonstrates that functional appliances can reduce ANB angles by 2–3 degrees through a combination of forward mandibular movement, forward condylar rotation, and restraint of maxillary forward growth. The timing of functional appliance therapy is crucial: treatment during the pubertal growth phase (identified by cervical vertebral maturation stages 3–5) maximizes the orthopedic response, with patients during peak growth velocity demonstrating the greatest changes in skeletal dimensions.
The mandibular response to functional appliance therapy includes increased condylar cartilage growth (demonstrated on CBCT and MRI studies), increased corpus length, and favorable changes in gonial angle, collectively reducing the skeletal discrepancy between maxilla and mandible. Dentoalveolar changes accompanying orthopedic correction include distal movement of maxillary molars (4–5 mm), mesial movement of mandibular molars (3–4 mm), and proclination of mandibular incisors. Long-term stability studies indicate that skeletal changes produced by functional appliances during Phase One are largely maintained into adulthood, with approximately 50–60% of the induced changes persisting permanently while remaining growth continues in the treated direction. Patients demonstrating horizontal or average growth patterns respond more favorably to functional appliance therapy than those with vertical growth patterns, in whom additional vertical opening may be contraindicated.
Fixed Appliance Utilization in Phase One
While removable expansion and functional appliances constitute the primary modality for most Phase One cases, selected patients with specific clinical presentations may benefit from limited fixed appliance therapy during the mixed dentition phase. Fixed appliance therapy in Phase One addresses anterior crossbites, severe anterior crowding with ectopic tooth position, or cases where precise three-dimensional tooth control is necessary before permanent dentition eruption. Early fixed appliance treatment typically involves bonding brackets to permanent first molars and incisors, avoiding primary teeth and erupting permanent canines and premolars. The wire sequencing for Phase One fixed appliances uses light continuous forces, typically beginning with 0.016 or 0.020-inch round wires progressing to rectangular wires as space becomes available and root development advances.
Fixed appliances in Phase One may be combined with functional mechanics using intermaxillary elastics or bite-jumping appliances to provide both skeletal guidance and precise dental control. Treatment duration for Phase One fixed appliance therapy typically ranges from 12–24 months, with transition to Phase Two comprehensive treatment planned after permanent dentition eruption and attainment of adequate stability. Careful patient selection and simplified wire mechanics minimize treatment burden and reduce risk of iatrogenic effects such as root resorption, white spot lesions, or decalcification. Follow-up care during and after Phase One fixed appliance treatment requires meticulous oral hygiene education, fluoride application protocols, dietary counseling, and frequent monitoring appointments (every 4–6 weeks) to manage emerging permanent teeth and assess treatment response.
Treatment Duration and Sequencing Considerations
Phase One treatment duration varies significantly based on the severity of the initial malocclusion, the specific appliance system selected, and the rate of dental and skeletal changes observed during active therapy. Removable expansion and functional appliance treatment typically requires 18–36 months of active wear, with longer treatment periods often yielding more complete skeletal correction. Fixed appliance Phase One treatment spans 12–24 months, with specific endpoints determined by correction of the primary problem (crossbite correction, space gain, or occlusal relationship improvement). The sequencing of Phase One and Phase Two treatment represents a critical consideration in comprehensive treatment planning; prolonged Phase One therapy may delay Phase Two initiation and prolong overall treatment duration, while premature transition to Phase Two may require re-opening of corrected problems or additional expansion during comprehensive treatment.
Following Phase One active treatment completion, many patients enter a retention/observation phase lasting 6–12 months, allowing final eruption of permanent canines and premolars while monitoring stability of achieved corrections. This observation phase informs the decision regarding Phase Two necessity and timing; some patients achieve substantial improvement during Phase One such that Phase Two may be limited to simplified finishing mechanics, while others require comprehensive fixed appliance therapy. Research by McNamara and colleagues (2001) found that strategic sequencing of Phase One interceptive treatment followed by Phase Two comprehensive treatment reduced overall treatment time by 4–8 months compared to delayed single-phase treatment initiated after complete permanent dentition eruption. Early planning and accurate diagnostic prediction enable clinicians to optimize treatment sequencing and minimize the cumulative burden of extended treatment duration.
Clinical Success Factors and Treatment Outcomes
Achievement of successful Phase One treatment outcomes depends on multiple clinical and patient-related factors. Patient age and skeletal maturity status—assessed using cervical vertebral maturation, hand-wrist radiographs, or chronological age combined with clinical assessment—significantly influence the magnitude of skeletal response and long-term stability. Younger patients (ages 6–8 years) undergoing early Phase One intervention may demonstrate greater orthopedic response, but also have a longer timeline until Phase Two completion, potentially increasing risk of relapse during the observation phase. Conversely, older mixed dentition patients (ages 10–12 years) demonstrate greater consistency of treatment response relative to timing and may require shorter Phase One treatment durations.
Patient compliance with removable appliance wear represents a critical success factor; functional appliances and removable expanders require 18–24 hours per day of wear to produce consistent orthodontic and orthopedic effects. Studies document that compliance variability directly correlates with treatment duration and outcome quality, with compliant patients achieving planned corrections in 50–80% of predicted time while non-compliant patients may require 2–3 times the planned duration or fail to achieve treatment objectives. Systematic appliance selection based on diagnostic criteria—such as choosing functional appliances for Class II patients with adequate intercanine width and normal-to-horizontal growth patterns—enhances the probability of favorable outcomes. Final assessment of Phase One treatment success includes achievement of the specific treatment objectives (crossbite correction, space gain, growth modification) documented through clinical examination, occlusal relationship assessment, and radiographic verification of skeletal and dental changes.
Limitations and When Not to Treat
Despite clear benefits in selected cases, Phase One treatment is not universally indicated and requires careful patient selection to avoid unnecessary treatment burden. Patients demonstrating mild malocclusions without functional compromise, dental crowding that may resolve with normal eruption patterns, or favorable space predictions based on mixed dentition analysis may benefit from observation without intervention. Additionally, patients with severe vertical growth patterns, anterior open bite tendency, or excessive vertical maxillary dimensions may experience worsening of vertical parameters with expansion therapy or functional appliance use, necessitating delayed treatment until skeletal maturity allows comprehensive surgical-orthodontic management.
Limitations of Phase One treatment include inability to predict all aspects of permanent dentition eruption, potential for relapse during the observation phase and subsequent Phase Two treatment, and variable response to orthopedic therapy based on individual growth patterns and biologic variation. Some patients fail to demonstrate expected skeletal response to functional appliances, requiring alternative treatment planning or acknowledgment that dental compensation may be necessary. Additionally, early extraction of primary teeth (serial extraction) carries risk of space loss or lateral closure if not precisely timed, potentially necessitating corrective measures during Phase Two. Economic considerations must also be acknowledged: Phase One treatment represents an additional cost beyond Phase Two treatment, and in some cases, delaying comprehensive treatment until permanent dentition eruption may prove more efficient and cost-effective while achieving equivalent esthetic and functional outcomes.
Conclusion
Phase One interceptive treatment during the mixed dentition period represents a valuable evidence-based approach for managing moderate to severe skeletal and dental discrepancies while capitalizing on remaining growth potential. Careful diagnostic evaluation, appropriate appliance selection, and appropriate patient sequencing enable clinicians to significantly reduce complexity of subsequent Phase Two treatment, shorten overall treatment duration, and improve long-term stability and esthetic outcomes. Strategic use of expansion therapy, growth modification, serial extraction, and selective fixed appliances addresses transverse, anterior-posterior, and vertical discrepancies during the optimal window of skeletal development, preventing progression toward severe malocclusions requiring surgical correction. When applied to carefully selected patients with adequate compliance and favorable growth characteristics, Phase One treatment represents a cornerstone of modern comprehensive orthodontic care.